Citations (1)
Keep up to date with the latest research on this topic with citation updates for this article.
Drug Design, Development and Therapy
Volume 15, 2021 - Issue
Original Research
No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects
Yu Kyong Kim1 Department of Clinical Pharmacology and Therapeutics, Chungbuk National University College of Medicine and Hospital, Cheongju, Republic of Korea
https://orcid.org/0000-0002-7868-1761View further author information
https://orcid.org/0000-0002-7868-1761View further author information, Jun Gi Hwang1 Department of Clinical Pharmacology and Therapeutics, Chungbuk National University College of Medicine and Hospital, Cheongju, Republic of Koreahttps://orcid.org/0000-0002-0965-0531View further author information
https://orcid.org/0000-0002-0965-0531View further author information & Min Kyu Park1 Department of Clinical Pharmacology and Therapeutics, Chungbuk National University College of Medicine and Hospital, Cheongju, Republic of Korea;2 Department of Pharmacology and Clinical Pharmacology, Dong-A University College of Medicine, Dong-A University Hospital, Busan, Republic of KoreaCorrespondence[email protected]
https://orcid.org/0000-0002-9851-7555View further author information
https://orcid.org/0000-0002-9851-7555View further author information